DiaCarta, MIODx to Codevelop Diagnostic to Predict Immunotherapy Response – GenomeWeb
|
DiaCarta, MIODx to Codevelop Diagnostic to Predict Immunotherapy Response
GenomeWeb NEW YORK (GenomeWeb) – DiaCarta and MIODx today said they plan to codevelop a diagnostic test to predict immunotherapy response based on MIODx's immune sequencing technology, ClonoMap. The test will be developed and validated at DiaCarta's CLIA … DiaCarta and MIODx Join Forces to Develop a Diagnostic Test to Predict Patient Responses to Immunotherapy |
